OctopusyX BioConsulting (Olivier REVELANT, @octopusyx2), a member of Eurobiomed, and BioPharmAnalyses (Anne-Lise BERTHIER, @anneliseberthie) are proud to announce the launch of their new report entitled “AAV-based Gene Therapy Products: Ongoing Clinical Trials”. This >200 pages report provides a unique exhaustive overview of 116 ongoing trials for the treatment of 40 diseases (as of June 2020). More thant 80 AAV based products described.
See Our Sample Pages (http://biopharmanalyses.fr/wp-content/uploads/2020/06/sample-pages.pdf)
Therapeutic Areas Covered
Inherited Metabolic Diseases